COMMUNIQUÉS West-GlobeNewswire
-
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
14/04/2026 -
Neomorph to Highlight Progress in Targeted Protein Degradation Science at the American Association for Cancer Research Annual Meeting
14/04/2026 -
Hemp Hop Announces 420 Deals in Charlotte, NC with Buy 3, Get 1 Free 2026
14/04/2026 -
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
14/04/2026 -
Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model
14/04/2026 -
HealthEdge® Partners with Ellipsis Health to Scale Care Management Through AI-Powered Virtual Nursing
14/04/2026 -
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
14/04/2026 -
Haystack Health Appoints Digital Health Leader Bill Snyder as Chief Executive Officer
14/04/2026 -
Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
14/04/2026 -
TOMI Reports Strong Q1 2026 Sales of High-Margin BIT Solution, Indicating Positive Growth Trends
14/04/2026 -
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
14/04/2026 -
GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026
14/04/2026 -
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
14/04/2026 -
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
14/04/2026 -
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
14/04/2026 -
Extendicare Announces Closing of $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
14/04/2026 -
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
14/04/2026 -
Nextech Reduces Healthcare’s Payment Reconciliation Burden with Reimagined Embedded Payment Processing Platform
14/04/2026 -
Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613
14/04/2026
Pages